Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
02/10/1998 | US5716955 Cytokine inhibitor |
02/10/1998 | US5716777 Regulation of meiosis using sterols |
02/06/1998 | CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
02/05/1998 | WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens |
02/05/1998 | WO1998004517A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
02/05/1998 | WO1998004256A1 Amino acid compositions and use thereof in immunosuppression |
02/05/1998 | WO1997033912A3 Uses of gdnf and gdnf receptor |
02/05/1998 | CA2261692A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
02/05/1998 | CA2260956A1 Amino acid compositions and use thereof in immunosuppression |
02/04/1998 | EP0822185A1 B-3-adrenergic agonists as antidiabetic and antiobesity agents |
02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
02/04/1998 | EP0821585A1 USE OF $g(a) 1L? AGONISTS IN THE TREATMENT OF INCONTINENCE |
02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
02/03/1998 | US5714508 Inhibitors of angiotensin ii |
02/03/1998 | US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
02/03/1998 | US5714473 Chemotherapy; mixture with alkali metal citrate |
02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
02/03/1998 | CA1339660C Derivatives of cyclohexane |
01/31/1998 | CA2211866A1 .beta.-adrenergic agonists |
01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
01/29/1998 | WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs |
01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
01/29/1998 | WO1998003189A1 Use of conantokins |
01/29/1998 | WO1998003067A1 S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
01/29/1998 | DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments |
01/29/1998 | CA2261570A1 Use of conantokins |
01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
01/29/1998 | CA2256736A1 New triazolopurines, method of preparing them and their use as drugs |
01/28/1998 | EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
01/28/1998 | EP0820445A1 Inhibitors of farnesyl-protein transferase |
01/28/1998 | EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
01/28/1998 | EP0820426A1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION |
01/28/1998 | EP0820302A1 Combination compositions containing benazepril or benazeprilat and valsartan |
01/28/1998 | EP0820294A1 Use of nitric oxide-releasing agents to treat impotency |
01/28/1998 | EP0820290A1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
01/28/1998 | EP0820288A1 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
01/28/1998 | EP0641791B1 Novel benzothiophene derivative |
01/28/1998 | CN1171743A Novel tumor suppressor gene HIC-1 |
01/28/1998 | CN1037179C 1, 4 -benzoxazino derivatives |
01/28/1998 | CN1037176C Benzenealkanoic acids for cardiovascular diseases |
01/27/1998 | US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
01/27/1998 | US5712294 Antiinflammatory agents |
01/27/1998 | US5712287 Method of treating urinary bladder dysfunctions |
01/27/1998 | US5712271 Method of treating urinary bladder dysfunctions |
01/27/1998 | US5712122 Carboxy terminal peptide-extended proteins |
01/24/1998 | CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
01/22/1998 | WO1997035591A3 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
01/21/1998 | EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
01/21/1998 | EP0819009A1 Ovulation triggering drugs |
01/21/1998 | EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
01/21/1998 | EP0625977B1 Piperazine derivatives as 5-ht1a antagonists |
01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
01/21/1998 | CN1171109A Novel quinuclidine derivatives and medicinal composition thereof |
01/21/1998 | CN1171051A Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception |
01/21/1998 | CN1170719A Estrogenic agents |
01/20/1998 | US5710275 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
01/20/1998 | US5710247 Process and intermediates for the synthesis of LHRH antagonists |
01/20/1998 | US5710171 Anticancer and antitumor agents |
01/20/1998 | US5710169 Therapeutic heterocycles |
01/20/1998 | US5710163 Benzo f!quinolinones |
01/20/1998 | US5710151 Method of treating urinary bladder dysfunctions |
01/20/1998 | US5710149 Piperazine derivatives as 5-ht antagonists |
01/20/1998 | US5710139 Heterocyclic compounds |
01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
01/20/1998 | CA2059000C Fused-ring aryl substituted imidazoles |
01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
01/15/1998 | WO1998001143A1 Use of artichoke (cynara) extracts |
01/14/1998 | EP0818453A1 Benzothiophene compounds and methods of use |
01/14/1998 | EP0817861A1 Gene transfer into the kidney |
01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
01/14/1998 | EP0817775A1 Quinazoline derivatives |
01/14/1998 | EP0817645A1 Method for treatment of benign prostatic hypertrophy |
01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
01/14/1998 | EP0662950B1 Benzenealkanoic acids for cardiovascular diseases |
01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
01/13/1998 | US5708023 Nonirritating gel for skin |
01/13/1998 | US5708020 Arylalkyl(thio)amides |
01/13/1998 | US5708016 Pseudopeptides derived from neurokinins |
01/13/1998 | US5708010 Methods of inhibiting myeloperoxidase activity |
01/13/1998 | US5708009 Methods of inhibiting myeloperoxidase activity |
01/13/1998 | US5707999 Urogenital disorders |
01/13/1998 | US5707980 Administering 1a,25-dihydroxyvitamin d4 to patient |
01/13/1998 | US5707826 Transpeptidation, replacing terminal portion of peptide sequence with another sequence, forming amide at c-terminal position in one step |
01/10/1998 | CA2206997A1 Benzothiophene compounds and methods of use |
01/08/1998 | WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof |
01/08/1998 | WO1998000411A1 Prenyl transferase inhibitors |
01/08/1998 | WO1998000390A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
01/08/1998 | WO1998000152A1 Non-aqueous protic peptide formulations |
01/08/1998 | WO1998000135A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
01/08/1998 | WO1998000126A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
01/08/1998 | DE19627376A1 Verwendung von Artischocken-(Cynara)-Extrakten Use of artichoke (Cynara) extracts |
01/08/1998 | CA2259403A1 Non-aqueous protic peptide formulations |